Introduction
Type 2 diabetes mellitus (T2DM) is associated with cognitive dysfunction and a twofold increased risk of dementia.(1) The aetiology is incompletely known, but vascular disease is likely to play a role. (1) In the general population vascular disease, in particular cerebral small vessel disease (SVD), is a major contributor to ageing related cognitive decline and dementia.(2) On conventional magnetic resonance imaging (MRI) SVD can be visualized as white matter hyperintensities (WMH), lacunar infarcts, and microbleeds.(3) However, these conventional markers of SVD do not capture the full burden of cerebral microvascular damage. Neuropathological studies have identified microinfarcts as another common microvascular pathology that is linked to ante-mortem cognitive decline and dementia. (4) T2DM is a known risk factor for vascular disease, affecting both large and small vessels.
Microvascular complications of T2DM appear in the retina, peripheral nervous system, kidney, and probably also the brain. Ultra-high resolution MRI now, for the first time, permits visualization of cortical microinfarcts in vivo (5) and also greatly enhances the detection of cerebral microbleeds. (6) We hypothesized that microinfarcts and microbleeds are more common in patients with T2DM than in controls and that these lesions are associated with cognitive dysfunction. The present study investigated the presence of cortical microinfarcts and cerebral microbleeds with 7 tesla (7T) in patients with T2DM and in age-matched nondiabetic controls, and explored the relationship between these microvascular lesions and cognitive performance. 
Methods

Study population
Patients were recruited through six general practitioners as part of the second Utrecht Diabetic Encephalopathy Study (UDES2). (7) Eight hundred sixty-four randomly selected persons between 65 and 80 years of age (416 patients and 453 controls) received a letter to which they could respond if they were willing to participate. Two hundred sixty-three persons responded that they refused to participate; 168 responded that they were willing to participate, of which 63 patients with T2DM and 61 age-, sex-and education-matched controls met our inclusion criteria.
For inclusion, participants had to be 65-80 years of age, functionally independent and Dutch speaking. The diagnosis of diabetes had to be established at least one year prior to the study.
Controls had to have a fasting blood glucose <7.0 mmol/l. Exclusion criteria were contraindications for 7T MRI, a psychiatric or neurological disorder that could influence cognitive functioning (including dementia), recent non-disabling stroke (<2 years) or any disabling stroke, major depression or alcohol abuse. All subjects underwent a standardized evaluation, including medical history, physical and neurological examination, neuropsychological assessment, laboratory testing and both a 3T and 7T MRI, all on the same day.
In 26 participants (15 T2DM, 11 controls) no complete 7T MRI could be obtained due to patient related factors (e.g. contra-indications for 7T MRI or claustrophobia) or technical issues. One control participant proved to have a neurological disease that was not detected upon initial screening, leaving 97 subjects (48 T2DM, 49 controls) for the present study.
The study was approved by the medical ethics committee of the University Medical Center Utrecht and all subjects gave written informed consent. 
Medical history and biometric measurements
Medical history and medication use were assessed with standardized questionnaires. Blood pressure was measured at three different time points during the day and averaged. BMI was calculated as weight in kilograms divided by the square of height in meters. Fasting glucose, HbA1c and cholesterol levels were measured with standard laboratory testing. Impaired fasting glucose (IFG) was defined as fasting glucose levels of 5.6-6.9 mmol/L, according to the ADA criteria.
Data on microvascular complications were recorded. Retinopathy was defined as self-report of a physician diagnosis. Neuropathy was rated with the Toronto Clinical Neuropathy Scoring System,(8) but without a sensory test for temperature, so that the maximum score is 18 points.
A score >6 was considered as indicative of neuropathy. A patient was considered to have macroalbuminuria in case of an albumin-to-creatinine ratio of >300 µg/mg (according to ADA criteria), based on laboratory testing of a first midstream urine sample in the morning.
A macrovascular event was defined as a clinical history of myocardial infarction, stroke (not including TIA) or endovascular or surgical treatment of carotid, coronal or peripheral arterial disease.
MRI scanning protocol
Scans were acquired on a 7T MR system (Philips Healthcare, Cleveland, OH, USA) with a volume transmit and 16 or 32-channel receive head coil (Nova Medical, Wilmington, MA).
The standardized protocol included a dual-echo gradient echo sequence (repetition time 
Detection of microvascular lesions
Microvascular lesions were rated visually on 7T MRI scans by two independent raters, blinded to diabetes status and clinical information. In case of disagreement, consensus was obtained in a consensus meeting.
Cortical microinfarcts were defined as either small hyperintense (probably gliotic) lesions or hypointense with a hyperintense rim (probably cystic) lesions on the FLAIR image, corresponding with a hypointense lesion on the T1-weighted sequence (as previously described,(9) but without use of a T2-weighted sequence) ( Fig. 1) . Each lesion had to be detectable on sagittal, coronal, and transversal views, ≤3mm in length and restricted to the cortex to be classified as a microinfarct. Due to low signal-to-noise ratio on FLAIR images in the temporal lobes and cerebellum, these areas were not investigated.
Microbleeds were detected by the previously described semi-automatic method based on the radial symmetry transform (RST). (10) A slightly modified adaptation to the method was made by incorporating minimum intensity projection images. This improves the sensitivity and 
Other MRI measures
WMHs, cerebral infarcts and brain volumes were determined on 3T MRI scans. WMHs were outlined manually on the FLAIR images and their volumes were calculated. Brain infarcts were rated visually on FLAIR and T1-weighted images and classified as large vessel infarcts (>1.5 cm) or lacunar infarcts. Gray and white matter volumes were computed automatically on the T1-weighted image using the Freesurfer software (http://surfer.nmr.mgh.harvard.edu).
Volumes were expressed as a percentage of intracranial volume, which was outlined manually on the T2-weighted images.
Cognitive testing
All participants underwent a detailed standardized cognitive assessment as described earlier,(7) including tests for memory, information-processing speed and attention and executive function. For each cognitive test, raw test scores were standardized into z-scores and averaged to obtain one composite z-score per cognitive domain.
IQ was estimated with the Dutch version of the National Adult Reading Test, which is generally accepted to reflect the premorbid level of intellectual functioning.
Statistical analyses
Between-group differences in subject characteristics were analysed with an independentsamples t-test for continuous variables, χ 2 tests for proportions and Mann-Whitney U tests for memory -0.14 (-0.44;0.17), all p>0.05), but differences were not statistically significant.
MRI findings are described in Table 2 . Cortical microinfarcts were found in 19 (38%) controls (5 subjects showed >1 microinfarcts) and in 23 (48%) patients with T2DM (7 subjects showed >1 microinfarcts), p>0.05 (Fig. 2) . Microbleeds were present in 20 (41%) controls (10 subjects showed >1 microbleeds), and in 16 (33%) patients with T2DM (10 patients showed >1 microbleeds), p>0.05 (Fig. 2) . Microbleed distribution (i.e. presence and number of lobar and deep/infratentorial microbleeds) was also similar between the groups.
Cerebral gray matter volumes were smaller and lateral ventricle volumes larger in the patients than in the controls, but WMH and white matter volumes and occurrence of brain infarcts did not differ between the groups (Table 2) .
Across the two groups, cognitive performance on the three cognitive domains was not related did not show results that were different from the main analyses (data not shown).
Discussion
In this study on microvascular brain lesions in people with T2DM at ultra-high field MRI we did not observe an increased occurrence of microinfarcts or microbleeds compared to controls. Presence and number of microinfarcts or microbleeds were unrelated to cognitive performance.
Previous estimates on the occurrence of cerebral microinfarcts are solely based on autopsy studies, which identified them in around 24% of nondemented older individuals, with no significant differences between patients with T2DM and controls. 
